After publication of this article \[[@CR1]\] it was noticed that Figs. [2](#Fig1){ref-type="fig"} and [4](#Fig2){ref-type="fig"} (seen below) contained incorrect characters. The corrected figures can be seen below and the original article has also been updated to reflect this.Fig. 2Effect of DK226 on proliferation of human synovial fibroblast-like cells (HFLS) and of human synovial sarcoma cell line SW982. **a** Inhibition of tumor necrosis alpha (TNF-α)-induced proliferation of HFLS by hyaluronic acid (HA) or DK226 at increasing, equivalent HA concentrations. **b** Effect of exogenously added HA on the anti-proliferative effect of DK226 in HFLS. **c** Inhibition of proliferation of SW982 by methotrexate (MTX) or DK226 at increasing, equivalent MTX concentrations. **d** Effect of exogenously added anti-CD44 antibody (BU75) and anti-IgG2a (control antibody) on the anti-proliferative effect of DK226 in SW982. Values are means and standard error of the mean (SEM) (*n* = 4)Fig. 4Effect of DK226 on collagen-induced arthritis (CIA) in rat knee joints. **a** Effect of intra-articular hyaluronic acid (HA) (0.5 mg) or DK226 (0.5 mg HA-equiv, 26 nmol MTX-equiv) on knee swelling of the right knee (treated) shown on the *left panel*, and the effect in the left knee (untreated) shown on the *right panel*. **b** Histopathology of the right knee joints after treatment with intra-articular HA or DK226. Sections were stained with safranin O/fast green. *T* tibia, *M*meniscus, *F* femur. Scale bars indicate 100 μm. **c** and **d** Histologic analysis of synovial tissue (**c**) and lateral condyle of the femur (**d**). Values are means and standard error of the mean (SEM) (*n* = 3--10 in **a**, **c** and **d**: *n* = 3, Normal + vehicle; *n* = 9--10, CIA + vehicle, HA or DKA226). ^\#^ *P* \< 0.05: significantly different from Normal + vehicle group (Wilcoxon rank sum test). \**P* \< 0.05: significantly different from HA group (Wilcoxon rank sum test)
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